Literature DB >> 21953515

Administration of memantine and imipramine alters mitochondrial respiratory chain and creatine kinase activities in rat brain.

Gislaine Z Réus1, Roberto B Stringari, Gislaine T Rezin, Daiane B Fraga, Juliana F Daufenbach, Giselli Scaini, Joana Benedet, Natália Rochi, Emílio L Streck, João Quevedo.   

Abstract

Several studies have appointed for a role of glutamatergic system and/or mitochondrial function in major depression. In the present study, we evaluated the creatine kinase and mitochondrial respiratory chain activities after acute and chronic treatments with memantine (N-methyl-D: -aspartate receptor antagonist) and imipramine (tricyclic antidepressant) in rats. To this aim, rats were acutely or chronically treated for 14 days once a day with saline, memantine (5, 10 and 20 mg/kg) and imipramine (10, 20 and 30 mg/kg). After acute or chronic treatments, we evaluated mitochondrial respiratory chain complexes (I, II, II-III and IV) and creatine kinase activities in prefrontal cortex, hippocampus and striatum. Our results showed that both acute and chronic treatments with memantine or imipramine altered respiratory chain complexes and creatine kinase activities in rat brain; however, these alterations were different with relation to protocols (acute or chronic), complex, dose and brain area. Finally, these findings further support the hypothesis that the effects of imipramine and memantine could be involve mitochondrial function modulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21953515     DOI: 10.1007/s00702-011-0718-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  89 in total

1.  Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding.

Authors:  U Schlattner; T Wallimann
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

2.  A method for the estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera.

Authors:  B P HUGHES
Journal:  Clin Chim Acta       Date:  1962-09       Impact factor: 3.786

3.  Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity.

Authors:  Ruslan I Stanika; Natalia B Pivovarova; Christine A Brantner; Charlotte A Watts; Christine A Winters; S Brian Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-29       Impact factor: 11.205

4.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.

Authors:  J Garthwaite; S L Charles; R Chess-Williams
Journal:  Nature       Date:  1988-11-24       Impact factor: 49.962

5.  Mitochondrial function in Parkinson's disease.

Authors:  L A Bindoff; M Birch-Machin; N E Cartlidge; W D Parker; D M Turnbull
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

6.  Increased levels of glutamate in brains from patients with mood disorders.

Authors:  Kenji Hashimoto; Akira Sawa; Masaomi Iyo
Journal:  Biol Psychiatry       Date:  2007-06-15       Impact factor: 13.382

7.  Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport.

Authors:  A Cassina; R Radi
Journal:  Arch Biochem Biophys       Date:  1996-04-15       Impact factor: 4.013

8.  Molecular evidence for mitochondrial dysfunction in bipolar disorder.

Authors:  Christine Konradi; Molly Eaton; Matthew L MacDonald; John Walsh; Francine M Benes; Stephan Heckers
Journal:  Arch Gen Psychiatry       Date:  2004-03

Review 9.  Mitochondria in health and disease: perspectives on a new mitochondrial biology.

Authors:  Michael R Duchen
Journal:  Mol Aspects Med       Date:  2004-08

10.  An open-label, flexible-dose study of memantine in major depressive disorder.

Authors:  James M Ferguson; Richard N Shingleton
Journal:  Clin Neuropharmacol       Date:  2007 May-Jun       Impact factor: 1.592

View more
  4 in total

1.  Altered Monoamine and Acylcarnitine Metabolites in HIV-Positive and HIV-Negative Subjects With Depression.

Authors:  Edana Cassol; Vikas Misra; Susan Morgello; Gregory D Kirk; Shruti H Mehta; Dana Gabuzda
Journal:  J Acquir Immune Defic Syndr       Date:  2015-05-01       Impact factor: 3.731

Review 2.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

Review 3.  Preclinical and clinical evidence of antioxidant effects of antidepressant agents: implications for the pathophysiology of major depressive disorder.

Authors:  Guilherme A Behr; José C F Moreira; Benicio N Frey
Journal:  Oxid Med Cell Longev       Date:  2012-05-27       Impact factor: 6.543

4.  Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo.

Authors:  R Kaddurah-Daouk; M B Bogdanov; W R Wikoff; H Zhu; S H Boyle; E Churchill; Z Wang; A J Rush; R R Krishnan; E Pickering; M Delnomdedieu; O Fiehn
Journal:  Transl Psychiatry       Date:  2013-01-22       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.